The vector of anti-TEM8 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human TEM8. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-TEM8 antibody linked to CD28 signaling domains. And the vector product was designed for cell therapy that targets tumor vasculature, including the tumor vascular bed, for example, glioma and breast cancer. https://www.creative-biolabs.com/car-t/pcdcar1-tem8-h-28-t-551.htm

Your Trusted Partner to Advance Your Biological Therapeutics Discovery and Development

Antibody Therapy
Recombinant Antibodies
Bispecific Antibodies (BsAbs)
Antibody-Drug Conjugates (ADCs)
Single Domain Antibodies (SdAbs)
De Novo Antibody Discovery
De Novo Antibody Engineering

Cellular Therapy
Chimeric Antigen Receptor (CAR) Therapy Discovery and Development
Stem Cell Therapy Discovery and Development

Gene Therapy
Oncolytic Virus Discovery and Development
mRNA Discovery and Development
Viral Vector Discovery and Development
RNAi Therapeutics Discovery and Development
Formulation & Delivery Discovery and Development

Excellence in Custom Biotechnology and Pharmaceutical Services

Phage Display & Antibody Library Services
Premade Antibody & Peptide Library Services
Preclinical Animal Model Efficacy Services
PK/PD/Toxicity Evaluation Services
Non-Human Primate (NHP) Biologicals
Membrane Protein Drug Discovery Services